CLINICAL TRIALS PROFILE FOR GANITE
✉ Email this page to a colleague
All Clinical Trials for GANITE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT01093521 ↗ | A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients | Completed | Cystic Fibrosis Foundation | Phase 1 | 2010-04-01 | The purpose of this research study is to test the pharmacokinetics, safety, and tolerability of an intravenous infusion of a drug called Ganite (gallium nitrate) in patients with cystic fibrosis. We want to see this drug is safe and tolerable and to see if high levels of the drug are found in the sputum. Funding Source - Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) |
| NCT01093521 ↗ | A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients | Completed | Cystic Fibrosis Foundation Therapeutics | Phase 1 | 2010-04-01 | The purpose of this research study is to test the pharmacokinetics, safety, and tolerability of an intravenous infusion of a drug called Ganite (gallium nitrate) in patients with cystic fibrosis. We want to see this drug is safe and tolerable and to see if high levels of the drug are found in the sputum. Funding Source - Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) |
| NCT01093521 ↗ | A Pharmacokinetic and Safety Study of IV Gallium Nitrate (Ganite) in Cystic Fibrosis Patients | Completed | University of Washington | Phase 1 | 2010-04-01 | The purpose of this research study is to test the pharmacokinetics, safety, and tolerability of an intravenous infusion of a drug called Ganite (gallium nitrate) in patients with cystic fibrosis. We want to see this drug is safe and tolerable and to see if high levels of the drug are found in the sputum. Funding Source - Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) |
| NCT04294043 ↗ | IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study) | Recruiting | Cystic Fibrosis Foundation | Phase 1 | 2021-06-17 | The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NTM. Funding Source - FDA OOPD |
| NCT04294043 ↗ | IV Gallium Study for Patients With Cystic Fibrosis Who Have NTM (ABATE Study) | Recruiting | Chris Goss | Phase 1 | 2021-06-17 | The purpose of this study is to assess the safety and tolerability of two 5-day infusion cycles of IV gallium in adult patients with CF who are infected with NTM. Funding Source - FDA OOPD |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for GANITE
Condition Name
Clinical Trial Locations for GANITE
Trials by Country
Clinical Trial Progress for GANITE
Clinical Trial Phase
Clinical Trial Sponsors for GANITE
Sponsor Name
